IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Life science organizations of all sizes and complexity rely on the ICyte platform to streamline pharma market access and therapy commercialization. ICyte provides biotech and pharma manufacturers with world-class channel and patient data aggregation, contracts and pricing managed services, gross-to-net forecasting and accrual systems and expert launch and pricing transparency solutions.
With ICyte, pharmaceutical and biotech companies improve market access by quickly transforming patient, payer, complex transaction, and channel data into actionable insight.
There are three main components of the ICyte Platform: ICyte Applications, ICyte Analytics, and ICyte Data Refinery, which are supported by Governance and Cloud Infrastructure capabilities.
Unlike most enterprise systems, ICyte Analytics makes it easy to access data and insights. The unified portal interface provides Life Sciences manufacturers with single sign-on access across all ICyte channel, patient, contracts, pricing, and gross-to-net data and applications to easily create custom data-on-demand reporting and visualizations in one consolidated, easy-to-navigate website. Market Access teams will find it easy to visualize, extract, and integrate data into existing workflows and get the data they need when they need it. The platform also has a robust API that enables the use of existing business intelligence (BI) tools, if desired.
ICyte also supports analytics-as-a-service, which allows common models and metrics to be deployed as a centralized service across applications, data, and analytics uses. Key performance indicators (KPIs) specific to Life Sciences companies are built into the platform. Also included are advanced analytics such as forecasting, scenario modeling, and a machine-learning-powered recommendation engine.
Data Acquisition
The ICyte Platform supports multiple data acquisition technologies to onboard data securely. In addition to supporting all IntegriChain applications, ICyte’s data acquisition technologies make raw data actionable via direct, electronic data interchange (EDI), remote process automation (RPA), optical character recognition (OCR), and other data acquisition techniques. Our pre-built connectors and application programming interfaces (APIs) enable automation and reliable integration of data from third-party systems.
Comprehensive Data Sets
ICyte utilizes a wide array of data sets to support market access including:
Direct Sales & Channel Data
Payer Data
Patient Data
Data Integrity
The ICyte Platform uses data standardization and master data practices that ensure data quality across all IntegriChain products. The common repository supports a unified Market Access data model—an enterprise-class master data management (MDM) framework for products, customers, pricing, and more—and powers all IntegriChain applications, data, and analytics offerings. The repository supports data audit and lineage as well as a robust data lifecycle management process.
Orchestration
The ICyte Platform features an orchestration layer that defines and automates processes with sufficient provisions for process governance and benchmarking by leveraging services for job management, business rules management, workflow automation, and workload management.
Pharmaceutical companies that use ICyte for their market access needs see a wealth of operational benefits including:
Hassle-free Integration
The ICyte Platform easily integrates with leading revenue management applications, CRMs, ERPs, third-party sources, and datasets.
Seamless Interoperability with IntegriChain Products
The common architecture also means IntegriChain applications will integrate seamlessly with each other, regardless of when they’re purchased, and provide a standard way to publish data to enterprise/commercial data warehouses.
Investment Protection
The ICyte Platform is specifically designed to service market access functions. It co-exists with existing IT investments and infrastructure across CRM, ERP, data warehouse, and analytics systems.
Reduced Risk
The ICyte Platform is built with inherent security and scalability considerations. It is SOC 2 compliant and is hosted on AWS, leveraging proven and modern technology foundations to serve customers. All access to data is through secure protocols and encrypted in our services with the latest standards.
Maximize Value
Pharma manufacturers realize lower costs due to reduced vendor mix, less contracting complexity, and elimination of duplicate services.
All of IntegriChain’s products and services built on the ICyte Platform have a common configuration backbone. This not only accelerates time-to-value for pharmaceutical companies but also enables application interaction through shared metadata.
The ICyte Platform was developed with the largest and most dynamic pharmaceutical manufacturers in mind. Underneath, it is a fully-hosted SOC 2 certified cloud platform designed on a scalable, high-availability architecture and market-proven open source technologies.
<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>
